Atrium Therapeutics (RNA) Q3 2025 Earnings

Aug 7Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.21
-1.02
-0.84
-0.65

Details

Expected EPS
-0.958163
Actual EPS
-1.21
Surprise EPS
-0.25
Surprise Percent
-26.28%

Description

⁨Atrium Therapeutics⁩ (⁦RNA⁩) has reported earnings of ⁦-1.21⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts